[ Intravenous treatment of <font color="red">postpartum_2</font> <font color="red">anemia_2</font> with trivalent ferrum preparation ] . 
<br>
<br> AIM OF THE STUDY To assess the effectivity and safeness of intravenous treatment of <font color="red">pospartal_2</font> <font color="red">anemia_2</font> with trivalent ferrum preparation . 
<br> TYPE OF THE STUDY Prospective randomized study . 
<br> SETTING <font color="red">Department_1</font> <font color="red">of_1</font> <font color="red">Obstetric_1</font> <font color="red">and_1</font> <font color="red">Gynecology_1</font> <font color="red">2nd_1</font> <font color="red">Medical_1</font> <font color="red">Faculty_1</font> <font color="red">Charles_1</font> <font color="red">University_1</font> <font color="red">and_1</font> <font color="red">Teaching_1</font> <font color="red">Hospital_1</font> <font color="red">Motol_1</font> <font color="red">,_1</font> <font color="red">Prague_1</font> <font color="red">,_1</font> <font color="red">and_1</font> <font color="red">Department_1</font> <font color="red">of_1</font> <font color="red">Obstetric_1</font> <font color="red">and_1</font> <font color="red">Gynecology_1</font> <font color="red">1st_1</font> <font color="red">Medical_1</font> <font color="red">Faculty_1</font> <font color="red">and_1</font> <font color="red">Teaching_1</font> <font color="red">Hospital_1</font> <font color="red">Bulovka_1</font> <font color="red">,_1</font> <font color="red">Prague_1</font> <font color="red">._1</font> 
<br> METHODS 500 mg of sacharose ferric oxide ( Venofer ) was intravenously administered in two days regimen to <font color="red">50_2</font> <font color="red">women_2</font> <font color="red">with_2</font> <font color="red">clinical_2</font> <font color="red">and_2</font> <font color="red">lab_2</font> <font color="red">signs_2</font> <font color="red">of_2</font> <font color="red">postpartal_2</font> <font color="red">anemia_2</font> <font color="red">._2</font> The effect of administered drug was determined by comparsion of values of red blood count recovered before the treatment , 2nd or 3rd day post administration and two weeks later . The serum values of soluble transferrin receptors and ferritin were observed as markers of iron cell saturation and body iron reserves , too . Integral part of the study was the monitoring of adverse events during the treatment . 
<br> RESULTS Venofer came in sight as effective drug in the treatment of <font color="red">pospartal_1</font> <font color="red">anemia_1</font> and could become as the alternative to blood transfusion in mid - severe cases . It should be emphasized that we have not encountered any serious adverse event with intravenous trivalent saccharose ferric oxide treatment .